Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
2024-10-22
0:00
30:54
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
Fler avsnitt från "Radiology Podcasts | RSNA"
Missa inte ett avsnitt av “Radiology Podcasts | RSNA” och prenumerera på det i GetPodcast-appen.